October 6-8, 2021 – Inossia was present at the Eurospine meeting, which took place in Vienna, Austria. Inossia supported customer G21 in the exhibition of first bone adapted cement V-Flex, and networked with companies and clinicians working to improve the quality of life of patients suffering from spinal problems.
September 8-10, 2021 – Inossia was present at the Interdisciplinary Research Conference for Injectable Osteoarticular Biomaterials (Griboi) – Sardinia Spine and Stroke 2021 joint meeting in Sardinia. For the first time, Inossia and partner company G21 showcased and demonstrated V-Flex – A flexible bone cement for percutaneous vertebral augmentation procedures. Inossia also had the opportunity to […]
August 24, 2021 – Inossia receives ISO 13485 Quality Management System for Medical Devices certification. Certificate no. C002499 from RISE Research Institutes of Sweden AB. See the certificate
On Friday the 12th of March, 2021 the first patient of the study was enrolled. The study is a multicenter, prospective, single-blind, randomized, controlled clinical investigation to document the safety and efficacy of the use of V-Flex, a bone cement with adapted stiffness containing Inossia® Cement Softener, in patients with vertebral compression fractures caused by […]
Our CEO, Malin Nilsson, presented Inossia® to the Speaker of the National Assembly of Korea, H.E Mr Park Byeong-seug and His delegation at Uppsala castle. The visit was hosted by the Governor of the Uppsala province, Mr Göran Enander. Read the article on Uppsala Innovation Centre website.
This agreement will expand the market for G21 and at the same time we will have the possibility to create awareness of our coming product, the soft cement. We are very happy about this agreement and look forward to the launch of our soft cement.
Article published in OsteoporosNytt, a Journal from the Osteoporosis Association of Sweden. Link to article
During the Connect Day on the 19th of May 2020, Inossia® was awarded the Investors’ choice award! Connect Uppsala chose Inossia® out of all companies that pitched in-front of their investor network during the entire 2019. The motivation: Connect has the honor of awarding Malin & Cecilia from Inossia the “Investors’ Choice” award. Inossia pitched during Q3 and […]
Inossia® prepares for market launch. CEO Malin Nilsson talked with MedTech Maganize. You can read more about the article with medtechmagazine here link